// App-Quantinova.ai

: Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients

Researchers

Presenter

  • Sophie Reynolds

Principal Investigators

  • Kerry Lunn

  • Rona Beegan

  • Victoria Tear

  • Phillip D Monk

Medical Centers

  • Synairgen Research Limited, Southampton, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • 2'-5'-oligoadenylate synthase 1

  • C-X-C motif chemokine 10

Drug/Treatment

  • Interferon Beta

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • NCT03570359

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved